Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_12936a430b83d792f6361d58ccd1f934 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2503-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2517-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2267-0337 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2510-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2517-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2227-106 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2035-122 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5088 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K67-0271 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-0008 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-12 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01K67-027 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01K67-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01K67-033 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-85 |
filingDate |
2001-12-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2011-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ef1709baabbb8c957e70919267191408 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f49ba51cbd18134a471d172ce0111242 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1950625ee1f7ddaaf20dd5708a9649fc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_98b8c72ddc822e45ef5f272d5c1e7a6e |
publicationDate |
2011-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-8012456-B2 |
titleOfInvention |
Biological models capable of exhibiting secondary disease manifestations and useful for developing therapeutic drugs, diagnostic products and therapeutic or diagnostic procedures, methods of using same, and cells, tissues and organs derived therefrom |
abstract |
This invention provides novel animal models for a human pathogen that is capable of exhibiting analogous secondary disease manifestation. Other animal models for a human pathogen are provided by this invention which are capable of exhibiting analogous secondary disease manifestations and are also capable of responding to therapeutic or preventive measures to such secondary disease manifestations. Other animal models for human retrovirus infections are provided including lower primates and primate excluding any members of the order Anthropoidea. Compositions, drugs, products and procedures for therapeutic and diagnostic applications derived from the animal models of this invention are also described and provided. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9573972-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011280805-A1 |
priorityDate |
1997-06-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |